Vitamin Biosynthesis as an Antifungal Target
AbstractThe large increase in the population of immunosuppressed patients, coupled with the limited efficacy of existing antifungals and rising resistance toward them, have dramatically highlighted the need to develop novel drugs for the treatment of invasive fungal infections. An attractive possibility is the identification of possible drug targets within essential fungal metabolic pathways not shared with humans. Here, we review the vitamin biosynthetic pathways (vitamins A–E, K) as candidates for the development of antifungals. We present a set of ranking criteria that identify the vitamin B2 (riboflavin), B5 (pantothenic acid), and B9 (folate) biosynthesis pathways as being particularly rich in new antifungal targets. We propose that recent scientific advances in the fields of drug design and fungal genomics have developed sufficiently to merit a renewed look at these pathways as promising sources for the development of novel classes of antifungals. View Full-Text
Share & Cite This Article
Meir, Z.; Osherov, N. Vitamin Biosynthesis as an Antifungal Target. J. Fungi 2018, 4, 72.
Meir Z, Osherov N. Vitamin Biosynthesis as an Antifungal Target. Journal of Fungi. 2018; 4(2):72.Chicago/Turabian Style
Meir, Zohar; Osherov, Nir. 2018. "Vitamin Biosynthesis as an Antifungal Target." J. Fungi 4, no. 2: 72.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.